Selective reporting of clinical trial outcomes may be widespread. This study reports instances occurring in CONSORT-endorsing medical journals.
An article in the MAP newsletter examines how publication professionals could help to increase preclinical publishing standards.
A number of initiatives developed to prevent researchers from only reporting the most impressive outcomes of clinical trials are explored in an opinion piece from The BMJ.
Is your institute breaking European clinical trial reporting rules? Find out using the new EU trials tracker, part of the AllTrials initiative.
Gain a better understanding of issues surrounding the preparation of encore presentations for congresses.
The Publication Plan remembers Professor Doug Altman, founder of the EQUATOR network, who passed away last month.
Get up to date on how gender influences the academic publishing process and what can be done to establish gender equity.
Don’t forget! From 1 July 2018, ICMJE requires all reports of clinical trial data to include a data sharing statement.
Significance testing and p values are widely used in medical publications, but just how meaningful are they?
Missed the 14th Annual Meeting of ISMPP? Read the second part of our meeting report to get up to speed!
Can preprints be cited in the same way as papers published in a peer reviewed journal, or do we need to define new standards?
The CONSORT extension for reporting non-pharmacological interventions was introduced in 2008. A recent study looks at the impact of this guidance on reporting standards.
Are we too willing to accept big data as fact? Find out how scientific publishing can learn from common mistakes arising from bad data practice.
Missed TIPPA 2018? Read our meeting report to get up to speed!
Missed ISMPP EU 2018? Hannah Mace provides a summary of the meeting’s poster presentations.
Missed ISMPP EU 2018? Read our meeting report to get up to speed!